Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Genetica Molecular, |
RCV002274255 | SCV002549758 | likely pathogenic | Lynch syndrome 1 | 2022-06-03 | no assertion criteria provided | clinical testing | In the patient under study, a variant was found in exon 9 of the EPCAM gene, in a heterozygous state, consisting of a deletion of two nucleotides (c.904-1_904del), one of which is found in the intronic region adjacent to the exon 9, and the other at the first nucleotide of the same exon. This alteration would produce a stop codon in the first codon of exon 9 (p.(Ile302Ter)), stopping protein synthesis and leaving the protein without the last 13 amino acids. This alteration is unprecedented in mutational databases (ClinVar, LOVD-Variome, SITHER), population databases (GenomAD, ESP5400), as well as in reports or bibliography. There is a very close variant, c.904-2A>G (ClinVar: VCV000239144.3. dbSNPs: rs878854496), which, despite being of a different nature, causes a disruption in splicing with the production of a probable abnormal protein. It has been observed that most patients with deletions at the 3' end of the EPCAM gene report inactivation of MSH2. This patient has a defective MSH2 protein (iNMUNOHISTOCHEMISTRY) and positive CNVs analysis in the MSH2 gene |